Even though respiratory infections and ailments are already described as contraindications for HBOT, the case of SARS-CoV-2 is undoubtedly an exception. Presently, the possible utilization of HBOT while in the COVID-19 has actually been specifically regarded, exposing leads to several controlled clinical trials. Additionally, using this course of a